A randomised trial of weekly cetuximab and radiation versus weekly cisplatin and radiation in good prognosis loco regionally advanced HPV-associated oropharyngeal squamous cell carcinoma
Primary Sponsor
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
189
Closing Date of Accrual
7th June 2018
Trial Chairperson
Prof Danny Rischin and A/Prof June Corry
Trial Contact
anetta.matera@petermac.org
Clinical Trial Registration
Related Post
October 18, 2022
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
September 6, 2022
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
